2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Molecular Testing, Omics Technologies, Pathology, Bioinformatics, Clinical Procedures, Computational Biology, Emerging Technologies, Gene Editing, Profiling, Treatment Considerations, Drug Development, Therapy Sequence, Biological Therapies, Transplantation, (CAR)-T Cell Therapies, Workforce, Adverse Events, Artificial Intelligence (AI), Computer Vision, Deep Learning, Generative AI, Machine Learning, Natural Language Processing, Biological Processes, Pathogenesis, CHIP, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Microbiome, Molecular Biology, Multi-Systemic Interactions, Clinical Practice (Health Services and Quality), Quality Improvement, Systems-Based Hematology, Diseases, Bone Marrow Failure Syndromes, Lymphoid Malignancies, Lymphoid Leukemias, Lymphomas, Plasma Cell Disorders, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Metabolic Disorders, Measurable Residual Disease, ALL, CLL, LGL, Hodgkin Lymphoma, Research, Fundamental Science, AML, APL, Translational Research, MDS, MPN, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Real-World Evidence, Registries, Survivorship, Study Population, Human, Adult, Elderly
PAPER

4356 Rapid copy number variation enables Enterococcus faecium adaptation to diet and drug exposures in severely dysbiotic gut microbiomes

Tyler Funnell, PhD, Carlos Pardo De La Hoz, PhD2, Jonathan Peled, MD/PhD3, Joao B. Xavier, PhD4, Jenny Paredes, PhD5, Teng Fei, PhD6, Marcel R.M. van den Brink Jr, M.D., Ph.D.7
1 City of Hope National Medical Center, Los Angeles, California, United States
2 Memorial Sloan Kettering Cancer Center, New York, New York, United States
3 Memorial Sloan Kettering Cancer Center, New York, New York, United States
4 Memorial Sloan Kettering Cancer Center, New York, New York, United States
5 City of Hope National Medical Center, Los Angeles, California, United States
6 Memorial Sloan Kettering Cancer Center, New York, New York, United States
7 City of Hope National Medical Center, Los Angeles, California, United States

Background

Domination of the gut by Enterococcus predicts shorter survival in allogeneic hematopoietic cell transplantation (allo-HCT) recipients and is a common mode of microbiome injury in these patients. Although allo-HCT remains a curative immunotherapy for hematologic malignancies, it often causes serious complications including graft-vs-host disease and bloodstream infections, both of which are also predicted by Enterococcus domination. Therefore, understanding the factors promoting the expansion and persistence of Enterococcus during the peri-transplant period is crucial for managing this pernicious form of dysbiosis.

Structural variants (SVs) drive Enterococcus pathoadaptation; for example, a study reported that an insertion sequence upstream of a folate transporter gene in E. faecium improved fitness (Grieshop et al. Nature 2026). Bacterial copy number variation (CNV), a form of SV, has been associated with antibiotic heteroresistance, as well as human health, host genetics, and response to immunotherapy. Studying CNVs offers a powerful way to identify genes conferring survival advantages. Allo-HCT recipients are closely monitored during the peri-transplant period, which permits frequent and longitudinal collection of stool during a period of severe microbiome disruption. This provides an excellent opportunity to study bacterial genomic heterogeneity and rapid population dynamics within the gut microbiome. 

Methods

We assembled the largest collection of E. faecium copy number (CN) profiles derived from patient gut microbiomes. We aggregated public shotgun sequencing data from Memorial Sloan Kettering Cancer Center and Stanford University Medical Center (Siranosian et al. Nat Commun 2022). By analyzing 2,706 samples from 835 allo-HCT patients, we generated 877 quality-controlled CN profiles. We detected 41 highly variable regions (HVRs), characterized by frequent CN differences across samples. Using Generalized Estimating Equations models, we associated HVR CN with relative abundance, sample exposure status to 23 drugs, and dietary intake of 9 food groups and 3 nutrients aggregated from two days prior to stool collection.

Results

We detected 14 HVRs associated with relative abundance of E. faecium (P<0.05). Notably, we observed higher relative abundance of populations harboring a duplication that contains two lactose transporter genes. This aligns with our previous finding that lactose exacerbates Enterococcus growth following antibiotic exposure (Stein-Thoeringer et al. Science 2019). Furthermore, preliminary survival analysis identified specific HVRs that associated with overall patient survival (P<0.05).

Leveraging detailed dietary data available for 124 samples from 32 patients with E. faecium CN profiles (Dai et al. bioRxiv 2024, Paredes et al. bioRxiv 2026), we found that vegetable intake was associated with lower CN for two HVRs (P<0.05) that were positively associated with relative abundance. Additionally, sugar intake positively correlated with the CN of three HVRs (P<0.05). One of these HVRs was also positively associated with relative abundance, while the other two contain genes of interest, including a glucose uptake protein and a multidrug ABC transporter permease. We also identified 34 associations between 12 drugs (e.g. metronidazole) and 17 HVRs (P<0.05), consistent with a model in which drug and nutrient exposures select for specific CN configurations.

In patients with longitudinal sampling, we found greater overall CN changes following exposure to piperacillin/tazobactam or meropenem in paired serial samples containing the same dominant strain (P<0.05). HVRs associated with relative abundance, drug exposures, and dietary intake often increased in CN then reverted to copy-neutral states over the course of days or weeks. This volatility highlights CN variation as a rapid and reversible mechanism for adaptation within individual microbiomes.

Conclusions

Building on our previous findings that sugar-rich foods and specific drug exposures predict day-to-day Enterococcus expansion, we define a broader set of selective pressures that shape genomes within gut populations during the peri-transplant period. The specific patterns of genomic loss and amplification associated with these exposures likely provide Enterococcus with a growth advantage that promotes domination. Ultimately, our work suggests specific E. faecium CNVs could serve as novel markers or mechanistic drivers of poor patient outcomes.

Tyler Funnell, PhD: No relevant conflicts of interest to declare.